Bandhan MF Fund Buys More Amanta Healthcare, Crosses 5% Stake

OTHER
Whalesbook Corporate News Logo
AuthorAarav Shah|Published at:
Bandhan MF Fund Buys More Amanta Healthcare, Crosses 5% Stake
Overview

Bandhan Small Cap Fund acquired 21,603 shares in Amanta Healthcare, bringing its total holding to 5.0124%. The March 28, 2026, disclosure complies with SEBI takeover rules and signals ongoing institutional interest in the pharma company.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Bandhan MF Crosses 5% Stake in Amanta Healthcare

Bandhan Mutual Fund has crossed a significant threshold by increasing its stake in Amanta Healthcare Limited to over 5.01%. This move, reported on March 28, 2026, follows the acquisition of an additional 21,603 shares by its Bandhan Small Cap Fund. The fund's total holding now stands at 5.0124% of the pharmaceutical company's paid-up capital and voting rights.

Regulatory Milestone and Disclosure

The acquisition is notable as it pushes Bandhan Small Cap Fund's holding past the 5% mark in Amanta Healthcare. Under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011, crossing this threshold mandates public disclosure. This filing fulfills that requirement and highlights sustained institutional interest. Amanta Healthcare's total equity share capital was INR 38.83 crore as of March 2026.

Amanta Healthcare's Market Position

Amanta Healthcare, which specializes in sterile liquid products and medical devices, launched its Initial Public Offering (IPO) in September 2025, listing on the BSE and NSE on September 9, 2025. Bandhan Small Cap Fund, known for its investment strategy, had previously held a stake in the company, with 1,549,467 shares reported as of December 31, 2025.

Industry Peers and Sector Outlook

Amanta Healthcare operates within India's dynamic pharmaceutical sector, a field marked by strong competition from major companies such as Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Cipla, and Torrent Pharmaceuticals. These established players also offer extensive product ranges and possess significant global reach, competing in similar therapeutic areas.

What Investors Will Watch Next

Investors will likely monitor any further stake movements by Bandhan Small Cap Fund or other institutional investors. Key focus areas will also include Amanta Healthcare's quarterly financial results and operational updates following its IPO. Broader trends in the Indian pharmaceutical and healthcare sectors, as well as the potential for future open offers if stakes continue to rise significantly, will also be important indicators.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.